20043 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application; Pulmonary tract; Aromatherapy; Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy; for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
PHARMACEUTICAL COMPOSITION COMPRISING ENSIFENTRINE
#302ONCE-DAILY TREATMENT OF PULMONARY FIBROSIS
#303Dry powder treprostinil for the treatment of pulmonary hypertension
#304PEGylated synthetic KL4 peptide, Compositions and Methods Thereof
#305Composition and method for spray drying an adjuvant vaccine emulsion
#306INHALABLE COMPOSITION COMPROMISING CYCLODEXTRIN FOR USE IN THE TREATMENT OF NASAL INFLAMMATIONS
#307NEW THERAPEUTIC APPROACH TO LUNG DISEASE
#308INHALED IVERMECTIN
#309USE OF CICLESONIDE FOR THE TREATMENT OF RESPIRATORY DISEASES
#310INHALABLE DRY POWDERS
#311Improved administration of glycylcyclines by inhalation
#312Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's disease
#313An Inhaler For Electronically Supervised Parenteral Administration of a Pharmaceutical Composition
#314Inhalable imatinib formulations, manufacture, and uses thereof
#315COMPOSITIONS FOR THE TREATMENT OF VIRAL PULMONARY INFECTIONS
#316COMPOSITIONS FOR THE TREATMENT OF VIRAL PULMONARY INFECTIONS
#317Novel Codon-Optimized CFTR MRNA
#318NEBULIZED IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
#319POWDER FORMULATION FOR INTRANASAL ADMINISTRATION, AND MANUFACTURING METHOD THEREOF
#320ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS
#321METHODS FOR TREATING CYSTIC FIBROSIS
#322Dry powder inhaler and system for drug delivery
#323Method and formulation for inhalation
#324INHALED IMATINIB FOR PULMONARY HYPERTENSION
#325INHALABLE DRY POWDER FORMULATIONS COMPRISING ANGIOGENESIS INHIBITORS
#326Devices and methods for delivering dry powder medicaments
#327PEPTIDE YY PHARMACEUTICAL FORMULATIONS, COMPOSITIONS, AND METHODS
#328Methods and compositions for treating mucosal tissue disorders
#329PDE5 inhibitor powder formulations and methods relating thereto
#330CANNABIS INHALATION PRODUCTS AND METHODS OF PRODUCTION THEREOF
#331Lipo-glycopeptide cleavable derivatives and uses thereof
#332INHALABLE SUSTAINED THERAPEUTIC FORMULATIONS
#333Acetylcholinesterase Inhibitors for Treatment of Dermatological Conditions
#334AEROSOL TYROSINE KINASE INHIBITOR COMPOUNDS AND USES THEREOF
#335Methods and compositions for treatment of pulmonary hypertension and other lung disorders
#336METHODS OF TREATMENT FOR DISEASE FROM CORONAVIRUS EXPOSURE
#337Rapamycin for the treatment of lymphangioleiomyomatosis
#338DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERY
#339Inhalable formulation of fluticasone propionate and albuterol sulfate
#340AEROSOLIZED FLUOROQUINOLONES AND USES THEREOF
#341COMBINATIONS OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2 ADRENORECEPTOR AGONIST
#342DRY POWDER FORMULATIONS FOR INHALATION
#343METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING ACUTE EXACERBATIONS WITH POLYCLONAL IMMUNOGLOBULIN
#344KIT FOR INHALED CHEMOTHERAPY, AND TREATMENT OF LUNG CANCER WITH SAID KIT
#345Compositions of Bedaquiline, Combinations Comprising Them, Processes for Their Preparation, Uses and Methods of Treatment Comprising Them
#346BIOLOGICALLY ACTIVE DRY POWDER COMPOSITIONS AND METHOD OF THEIR MANUFACTURE AND USE
#347Dry powder inhalation formulation and its use for the therapeutic treatment of lungs
#348PDE5 inhibitor powder formulations and methods relating thereto
#349DRY POWDER COMPOSITIONS WITH MAGNESIUM STEARATE
#350Methods of treatment using a JAK inhibitor compound
#351METHODS OF TREATING AUTOIMMUNE, RESPIRATORY AND INFLAMMATORY DISORDERS BY INHALATION OF ROFLUMILAST N-OXIDE
#352DRUG FOR USE AGAINST THE NOVEL CORONAVIRUS DISEASE, COVID-19
#353Therapeutic agent for phosphodiesterase inhibition and its related disorders
#354NEW COMPOSITION COMPRISING AMORPHOUS NANOPOROUS SILICA PARTICLES
#355COMPOSITIONS FOR THE TREATMENT OF VIRAL PULMONARY INFECTIONS
#356Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
#357Formulations of influenza therapeutics
#358ORONASAL CBD FORMULATIONS AND USES THEREOF
#359Inhalable powder formulations of alginate oligomers
#360INHALATION POWDER MEDICINE, EVALUATION METHOD THEREOF, AND USE THEREOF
#361Surfactant Formulations for Inhalation
#362Method for treating or mitigating Parkinson's disease using nicotine inhaler or nicotine nasal spray
#363INHALABLE MEDICAMENTS
#364Dry Powder Formulations for Messenger RNA
#365Application of Raman spectroscopy for the manufacture of inhalation powders
#366Method of treating hypoglycemia events in diabetes treatment
#367Treating Auto-Immune and Auto-Inflammatory Diseases
#368Lipophilic transport particles for cosmetic or pharmaceutical active ingredients
#369NICOTINE PARTICLES AND COMPOSITIONS
#370Dry powder inhaler
#371Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of Manufacture
#372PHARMACEUTICAL FORMULATION CONTAINING REMDESIVIR AND ITS ACTIVE METABOLITES FOR DRY POWDER INHALATION
#373Dry powder treprostinil for the treatment of pulmonary hypertension
#374Dry powder treprostinil for the treatment of pulmonary hypertension
#375Dapsone formulations and methods of using same
#376Ketamine composition for use in a method of treatment of depression by pulmonary administration
#377COMPOSITIONS OF SURFACE-MODIFIED THERAPEUTICALLY ACTIVE PARTICLES BY ULTRA-RAPID FREEZING
#378DRY PHARMACEUTICAL COMPOSITION FOR INHALATION
#379PRODUCTS OF MANUFACTURE FOR THE TREATMENT, PREVENTION AND AMELIORATION OF MICROBIAL INFECTIONS
#380PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, PREVENTING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#381Treatment for interstitial lung disease
#382Therapy for reducing brain damage
#383COMPOSITIONS AND METHODS FOR DELIVERING CFTR POLYPEPTIDES
#384PHARMACEUTICAL COMPOSITIONS OF RIBAVIRIN
#385COMPOSITION CONTAINING A MUCOLYTIC AGENT FOR THE TREATMENT OF MUCUS HYPERSECRETION AND A DEVICE FOR THE DOSING THEREOF
#386PEPTIDE YY PHARMACEUTICAL FORMULATIONS, COMPOSITIONS, AND METHODS
#387Pharmaceutical Compositions
#388Application of raman spectroscopy for the manufacture of inhalation powders
#389THERAPEUTIC LUNG REPAIR BY INHALATION OF LUNG SPHEROID CELL-SECRETED FACTORS
#390Carrier particles for dry powder formulations for inhalation
#391TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS
#392Prostacyclin compounds, compositions and methods of use thereof
#393Dry powder formulation of caveolin-1 peptides and methods of use thereof
#394METHOD AND COMPOSITION FOR TREATING OBESITY
#395AZAINDOLE DERIVATIVES AS RHO-KINASE INHIBITORS
#396N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO
#397DRY POWDER DRUG DELIVERY SYSTEM
#398Use of ultrarapid acting insulin
#399THERAPEUTIC COMBINATIONS OF DRUGS FOR TREATING, PREVENTING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#400Antibiotic compositions for treating bacterial infections
#401Salt of cysteamine for the preparation of highly respirable particles
#402Dithiolsaccharide mucolytic agents and uses thereof
#403Compositions Containing Verteporfin, Ribavirin, Gemcitabine, or Combinations Thereof and Methods of Use for Treating COVID-19, Cancer, or Non Cancer Diseases
#404IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS
#405Compositions containing verteporfin, ribavirin, gemcitabine, or combinations thereof and methods of use for treating COVID-19, cancer, or non cancer diseases
#406Inhalable rapamycin formulation for treating age-related conditions
#407FLUTICASONE FUROATE IN THE TREATMENT OF COPD
#408Methods and compositions for treatment of pulmonary hypertension and other lung disorders
#409System and method for salt holding integratable pillow
#410JAK1 selective inhibitors
#411VIP and VIP agonists, nanoparticles, and uses in inflammatory T-cell mediated disease
#412Methods of treatment of asthma and COPD
#413Methods of treating brain disorders
#414Dry powder formulations for inhalation
#415MODULATORS OF ENaC EXPRESSION
#416Inhibitor of p38 MAP kinase
#417Compositions and methods for delivering pharmaceutical agents
#418COMPOSITIONS AND METHODS FOR TREATING ELASTIC FIBER BREAKDOWN
#419Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
#420Compositions and methods for delivering pharmaceutical agents
#421Surfactant Formulations for Inhalation
#422POWDER FILLING PROCESSES
#423Nanocrystal microparticles of poorly soluble drugs and methods of production and use thereof
#424DRY POWDER VANCOMYCIN COMPOSITIONS AND ASSOCIATED METHODS
#425FLAVOURED NICOTINE POWDER INHALER
#426DRY POWDER INHALER
#427Topical formulations comprising montelukast and combinations with mussel adhesive proteins
#428ANTIFUNGAL FORMULATIONS FOR PULMONARY ADMINISTRATION COMPRISING ITRACONAZOLE
#429Coating method
#430Polymer
#431Diketopiperazine salts for drug delivery and related methods
#432Method of treating diabetes type 2 by administering ultrarapid acting insulin
#433Dry powder compositions for intranasal delivery
#434PROPOFOL FORMULATIONS WITH NON-REACTIVE CONTAINER CLOSURES
#435Dry powder formulations of thymic stromal lymphopoietin (TSLP)-binding antibodies and methods of use thereof
#436Monovalent metal cation dry powders for inhalation
#437Methods of Treating Fungal Infections
#438PALONOSETRON FORMULATIONS AND USES THEREOF
#439Particles with RNA Cleaving Nucleobase Polymers and Uses for Managing Inflammatory Disorders
#440Inhaled imatinib for treatment of pulmonary arterial hypertension (PAH)
#441INHALED IMATINIB FOR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH)
#442COMPOSITIONS AND METHODS FOR DELIVERING CFTR POLYPEPTIDES
#443DRY POWDER FORMULATIONS OF ALPHA-1 ANTITRYPSIN
#444Cromolyn compositions and methods thereof
#445Dry powder treprostinil for the treatment of pulmonary hypertension
#446Dry powder compositions for intranasal delivery
#447Pharmaceutical dry powder composition for inhalation comprising a thyroid hormone
#448Dry powder compositions for intranasal delivery
#449HIGH DOSE DELIVERY OF INHALED THERAPEUTICS
#450Inhalable dry powders
#451Method for treating pulmonary fibrosis using S100A3 protein
#452Dissolved C60 and method of producing dissolved C60
#453Olfactory delivery of therapeutic compounds to the central nervous system
#454FORMULATIONS OF KINASE INHIBITORS AND PROSTANOIDS
#455POWDERED FORMULATIONS OF CROMOLYN SODIUM AND IBUPROFEN
#456Methods of Treating or Preventing Acute Respiratory Distress Syndrome
#457Compositions and methods of making brittle-matrix particles through blister pack freezing
#458Antagonist antibodies that bind to human TGFB1, TGFB2 and to TGFB3 and their use for the treatment of lung fibrosis
#459POWDER PREPARATION, CARTRIDGE, AND DEVICE
#460METHOD AND COMPOSITION FOR ADMINISTERING PROSTAGLANDINS
#461Pyrazolopyrimidine inhibitors of JAK kinases and uses thereof
#462Use of ultrarapid acting insulin
#463Stable ascorbic acid compositions and methods of using the same
#464Medicament for prevention of treatment of rhinovirus infection
#465Azaindole derivatives as Rho-kinase inhibitors
#466Method for the Production of Commercial Nanoparticle and Microparticle Powders
#467CROMOLYN COMPOSITIONS AND METHODS THEREOF
#468Meta tyrosine derivatives as rho-kinase inhibitors
#469Diketopiperazine microparticles with defined specific surface areas
#470FLAVORED NICOTINE POWDER
#471Inhalable imatinib formulations, manufacture, and uses thereof
#472Acute Respiratory Distress Syndrome Therapeutic Agent
#473Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
#474Inhaled preparation of isoglycyrrhizic acid or salt thereof, and use in preparing drugs for treating respiratory system diseases
#475Inhalable dry powder cytidine analogue composition and method of use as a treatment for cancer
#476Dry powder compositions for intranasal delivery
#477Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
#478Dry powder inhaler
#479Inhalable imatinib formulations, manufacture, and uses thereof
#480Inhalable imatinib formulations, manufacture, and uses thereof
#481Unit aerosol doses for anticoagulation
#482Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
#483INHALABLE FORMULATIONS OF IMATINIB, IMATINIB METABOLITES, IMATINIB SALTS, THEIR MANUFACTURE, AND USES THEREOF
#484INHALABLE IMATINIB METABOLITE FORMULATIONS, MANUFACTURE, AND USES THEREOF
#485Inhalable imatinib formulations, manufacture, and uses thereof
#486METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE
#487Methods of treatment of asthma and COPD
#488Process for the preparation of umeclidinium bromide
#489DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERY
#490ANAEROBIC ANTIOXIDANT COMPOSITION
#491Compositions and methods for delivering pharmaceutical agents
#492DRY POWDER KETAMINE COMPOSITION FOR USE IN THE TREATMENT OF DEPRESSION BY PULMONARY ADMINISTRATION
#493THYMIC STROMAL LYMPHOPOIETIN (TSLP)-BINDING MOLECULES AND METHODS OF USING THE MOLECULES
#494Low Dose Pharmaceutical Powders for Inhalation
#495Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties and Methods of Administering the Same
#496Nutritive polypeptides and formulations thereof, and methods of production and use thereof
#497Therapies for treating and preventing chronic rhinosinusitis
#498Inhalable rapamycin formulation for the treatment of pulmonary hypertension
#499INHALABLE COMPOSITION OF CLOFAZIMINE AND METHODS OF USE THEREOF
#500Acetylcholinesterase inhibitors for treatment of dermatological conditions
#501DPI formulation containing sulfoalkyl ether cyclodextrin
#502Triptan Powders for Pulmonary Delivery
#503Rapamycin for the treatment of lymphangioleiomyomatosis
#504METHODS OF TREATMENT OF RESPIRATORY DISORDERS
#505COMBINATION OF FUROSEMIDE AND STEROIDS AND APPLICATION SYSTEM THEREFOR
#506NOVEL AEROSOL FORMULATIONS OF ONDANSETRON AND USES THEREOF
#507Inhalable dry powders
#508Combination therapy for treating pulmonary hypertension
#509Compositions and methods for delivering CFTR polypeptides
#510Formulations for the delivery of autophagy stimulating Trehalose
#511Glucocorticoid “nintedanib” particles and their use
#512Polyiodide resin powder for use with medical devices
#513Isotope enhanced ambroxol for long lasting autophagy induction
#514METHODS OF TREATING INFLUENZA-ASSOCIATED VIRAL PNEUMONIA
#515Inhalable particles
#516METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION
#517Inhaler article with occluded airflow element
#518METHODS FOR TREATING CYSTIC FIBROSIS
#519Cromolyn Compositions for Treatment of Pulmonary Fibrosis
#520Container with particles for use with inhaler
#521Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof
#522Methods and compositions for treating mucosal tissue disorders
#523MICROORGANISMS FOR USE AND DELIVERY TO THE RESPIRATORY SYSTEM
#524COMBINATIONS OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2 ADRENORECEPTOR AGONIST
#525Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of Manufacture
#526Diketopiperazine salts for drug delivery and related methods
#527Carrier particles for dry powder formulations for inhalation
#528PROMOTING LUNG GROWTH
#529Lipo-glycopeptide cleavable derivatives and uses thereof
#530FORMULATION COMPRISING GLYCOPYRROLATE, METHOD AND APPARATUS
#531Cromolyn Compositions for Treatment of Chronic Cough Due to Idiopathic Pulmonary Fibrosis
#532DRY POWDER VANCOMYCIN COMPOSITIONS AND ASSOCIATED METHODS
#533High capacity diketopiperazine microparticles and methods
#534Inhalable dry powder pharmaceutical composition
#535TREATMENT OF RESPIRATORY INFECTION WITH A TLR2 AGONIST
#536DELIVERY OF ACTIVE AGENTS
#537Dry powder inhaler with drug inlet mesh network
#538SUPERIOR CONTROL OF BLOOD GLUCOSE IN DIABETES TREATMENT
#539HYDROXYPROPYL METHYL CELLULOSE HARD CAPSULES AND PROCESS OF MANUFACTURE
#540Antifungal dry powders
#541Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties and Methods of Administering the Same
#542Dry powder formulations for inhalation
#543Methods of treatment using a JAK inhibitor compound
#544Devices and methods for delivering dry powder medicaments
#545Methods for treatment of pulmonary hypertension
#546NOVEL AEROSOL FORMULATIONS OF GRANISETRON AND USES THEREOF
#547Prostacyclin compounds, compositions and methods of use thereof
#548Method for making a micronized dry powder formulation of glycopyrrolate and magnesium stearate
#549AMINOGLYCOSIDE POTENTIATION FOR TREATMENT OF PULMONARY BACTERIAL INFECTION
#550NINTEDANIB FOR USE IN METHODS FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASES BY COADMINISTRATION WITH OLADATEROL
#551Process for manufacturing porous silica particles loaded with at least one bioactive compound adapted for lung, nasal, sublingual, and/or pharyngeal delivery
#552Compositions and methods of making brittle-matrix particles through blister pack freezing
#553Nasal compositions and method of use thereof
#554Dry Powder Inhaler
#555Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease
#556METHODS OF TREATING AUTISM SPECTRUM DISORDER USING AMINOSTEROL COMPOSITIONS
#557PROCESS FOR THE PREPARATION OF FLUTICASONE PROPIONATE FORM I
#558Powdered formulations of cromolyn sodium and alpha-lactose
#559Therapeutic agent for phosphodiesterase inhibition and its related disorders
#560DRY POWDER FORMULATIONS FOR MESSENGER RNA
#561Salt of a pyrimido[6,1-A]isoquinolin-4-one compound
#562AMBROXOL DRY POWDER FOR INHALATION USE WITH BRONCHIAL TARGET
#563COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS
#564Class of bifunctional compounds with quanternary ammonium salt structure
#565Pyrazolyl-ureas as kinase inhibitors
#566Cromolyn derivatives and related methods of imaging and treatment
#567SURFACTANT FORMULATIONS FOR INHALATION
#568MAST CELL STABILIZERS TREATMENT FOR SYSTEMIC DISORDERS
#569Monovalent Metal Cation Dry Powders
#570Aerosolized fluoroquinolones and uses thereof
#571Dry powder Vancomycin compositions and associated methods
#572IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS
#573JAK1 selective inhibitors
#574Composition and method for reducing hypoglycemia events in diabetes treatment
#575Methods of treatment using a JAK inhibitor compound
#576Particulate materials
#577INSULIN FORMULATIONS FOR RECONSTITUTION INTO HIGH CONCENTRATION LIQUID SOLUTIONS
#578System and method for controlling the harshness of nicotine-based dry powder formulations
#579High capacity diketopiperazine microparticles and methods
#580Dry powder compositions with magnesium stearate
#581Antagonist antibodies that bind to human TGFB1, TGFB2 and to TGFB3 and their use for the treatment of lung fibrosis
#582Co-spray drying of ciprofloxacin and colistin and the uses thereof
#583Methods of treating respiratory syncytial virus infections
#584Co-spray drying of meropenem and colistin and the uses thereof
#585Inhaled aspirin and magnesium to treat inflammation
#586COMPOSITION AND METHOD FOR INHALATION
#587Compositions and methods for treating elastic fiber breakdown
#588METHOD FOR IMPROVING THE PHARMACEUTIC PROPERTIES OF MICROPARTICLES COMPRISING DIKETOPIPERAZINE AND AN ACTIVE AGENT
#5893,5-DIAMINO-6-CHLORO-N-(N-(4-PHENYLBUTYL)CARBAMIMIDOYL) PYRAZINE-2- CARBOXAMIDE COMPOUNDS
#590Use of ultrarapid acting insulin
#591MAST CELL STABILIZERS TREATMENT FOR SYSTEMIC DISORDERS
#592INTEGRATED DEVICE FOR LUNG HEALTH ASSESSMENT
#593Dry powder inhaler compositions of 7-azoniabicyclo[2.2.1]heptane derivatives
#594USE OF CICLESONIDE FOR THE TREATMENT OF RESPIRATORY DISEASES
#595Preparation of respirable zafirlukast particles
#596Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
#597Isotope enhanced ambroxol for long lasting autophagy induction
#598Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
#599Process for the preparation of umeclidinium bromide
#600DRY POWDER DRUG DELIVERY SYSTEM